BioCentury
ARTICLE | Company News

Altus endocrine news

November 23, 2009 8:00 AM UTC

Altus filed for Chapter 7 bankruptcy. In September, the biotech said it will wind down its business operations and terminate substantially all of its employees. Altus' ALTU-238, a long-acting subcuta...